Ajay Samkaria: Is Reliance on Weak D Testing Sufficient in Modern Transfusion Practice?
Ajay Samkaria, Product and Application Manager at Diagast Transfusion Medicine, shared a post on LinkedIn:
“Is reliance on Weak D testing sufficient in modern transfusion practice?
While preventing anti-D alloimmunization remains critical, it does not address clinically significant antibodies against other Rh antigens such as C and E.
Without extended Rh phenotyping, we risk missing these antigens – potentially leading to alloimmunization and hemolytic disease of the fetus and newborn in future pregnancies.
- Time to think beyond the D antigen.
- Comprehensive Rh phenotyping should be part of routine practice, especially in females of childbearing age.
Weak D testing addresses D antigen variability but fails to identify sensitization risks from other Rh antigens such as C and E. Undetected exposure may result in clinically significant alloantibodies, contributing to hemolytic disease of the fetus and newborn.
Extended Rh phenotyping (C, c, E, e) and antibody screening are essential strategies to improve maternal and fetal outcomes.”

Stay updated with Hemostasis Today.
-
Jun 26, 2026, 13:02Turid Kjellevold: The Critical Role of Timely Hemostasis Testing
-
Jun 26, 2026, 10:59Wolfgang Miesbach: How Clonal Hematopoiesis May Explain Age-Related Mitochondrial Mutations
-
Jun 26, 2026, 10:52Chinua Onyebuchi: The Future of Stroke Care in Africa Lies in Strong Health Systems
-
Jun 26, 2026, 10:35Habtamu Milkias Wolde: New Insights into Stroke and Traumatic Brain Injury from Global Burden of Disease Data
-
Jun 26, 2026, 10:19Rytis Masiliūnas: Atrial Fibrillation and Stroke Care Disparities Across the Baltic Region
-
Jun 26, 2026, 10:11Kayla Kilani: First-Ever CT Perfusion Scan Performed Inside a Mobile Stroke Unit
-
Jun 26, 2026, 07:38Baraa Nassar: High Clinical Suspicion Is Essential for Early Diagnosis of CVST
-
Jun 26, 2026, 07:10Saleh Shamse Basha: Why APTT Alone Can Be Misleading During UFH Monitoring
-
Jun 26, 2026, 06:01Nicolas Hubacz: A Sharper Look at the Brain’s Vascular Landscape